Tuesday, November 14, 2017

Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA advisory about deadly risks associated with kratom - FDA Press Releases

A botanical substance known as kratom has raised significant concerns given its increasing prevalence and potential safety risks. The FDA has issued a public health advisory related to mounting concerns regarding risks associated with the use of kratom.

from Food and Drug Administration--Press Releases http://ift.tt/2z0rb8e
via IFTTT

No comments:

Post a Comment